A number of compounds have been reported to be specific inhibitors of protein kinases mediated by structural-based selectivity, but the development of specific inhibitors has not yet been addressed in plant science. Here we tested C2, C6, and N9-trisubstituted purines to determine the basic relationship between their chemical structure and inhibitory activity versus a plant mitogen-activated protein kinase (MAPK). Modification of substitution at positions C2 and N9 caused increased inhibitory activity of 6-benzylaminopurine analogs. In the case of 6-isopentenyladenine derivatives, the addition of a methyl group at position N9 caused at least 2-fold increased inhibitory activity, as compared with the addition of an isopropyl group. The data indicate that the selectivity and potency of inhibitors can be improved by modification of the chemical structure, suggesting that trisubstituted purines are powerful tools for probing biological processes and understanding the physiological roles of MAPK signaling.
Protein kinases are one of the major mechanisms for controlling intracellular responses to extracellular information, and ultimately they regulate cellular responses including proliferation, differentiation, secretion, apoptosis, and cell growth and development. The members of the protein kinase family can be categorized into three distinct classes based on the reversible transfer of the gamma-phosphate from ATP to specific serine, threonine, or tyrosine residues: the serine/threonine protein kinase, the tyrosine protein kinase, and the dual specificity protein kinase. 1) One prominent component that receives information from extracellular to intracellular is mitogen activated protein kinase (MAPK), which is encoded by a large family of serine/threonine protein kinases.
2) MAPK is organized in three-kinase modules consisting of MAPK kinase (MAPKK), an activator of MAPK, and a MAPKK kinase, which is linked in various ways to upstream receptors and downstream targets. In plant, as in yeast and mammals, MAPK cascades are activated by stress-related stimuli and growth factors. Analysis of the downstream mechanisms mediated by protein phosphorylation events, including MAPK cascades in animals, has been aided by the development of small synthetic molecules that have inhibition potential for a particular protein kinase.
3) The development of selective protein kinase inhibitors is of great importance in probing biological processes and is a promising approach to drug development. The ATP-binding site, which is presented on a large hydrophobic surface, has been focused on designing inhibitors that exploit differences in kinase structure and flexibility in order to achieve selectivity. 4) A number of compounds have been reported to inhibit particular serine/threonine protein kinase and are being used extensively in cell-based assays to study the physiological roles of the protein kinases that they are assumed to inhibit. 5, 6) For example, analogs of the antiinflammatory agent pyridinylimidazole, SmithKline Beecham (SB) compounds, showed highly potent and selective inhibitor effects on p38 but not on ERK2 or other serine/threonine kinases. 7, 8) SB203580 has been proposed to act in cells by stabilizing inactive conformation, and causes a reduction in p38 activation by MAPKKs.
9) The purine analogs roscovitine, olomoucine, and bohemine are used as potent inhibitors of cyclin-dependent kinase (CDK), 10) and were also shown to inhibit an alfalfa MAPK and tomato MAPKs. 11, 12) In higher plants, gain-of-function and the loss-offunction mutants are commonly used in the study of the physiological roles of MAPK, which, however, is limited by the availability of such mutants. In addition, functional redundancy can complicate analysis. There is no report so far of the development of inhibitors that are useful in probing biological processes and understanding the physiological roles of MAPK signalling in higher plants. Here, 39 compounds, including staurosporine, SB203580, and ML3403, were tested for plant MAPK inhibitory activity to determine the basic relationships between their chemical structure and inhibitory activity.
Materials and Methods
Growth of suspension culture cells and treatment. Photoautotrophic suspension culture cells of Lycopersicon peruvianum Mill. were used in the experimental system. 13) The suspension cells were subcultured every 2 weeks in Murashige and Skoog medium, and incubated with shaking under continuous light conditions under an atmosphere containing 2% w/v CO 2 . The cells were used in experiments in the y To whom correspondence should be addressed. Fax: +43-316-380-9880; E-mail: Tae.hyun@uni-graz.at Abbreviations: MAPK, mitogen-activated protein kinase; MAPKK, mitogen-activated protein kinase kinase; MBP, myelin basic protein; CDK, cyclin-dependent kinase second week after sub-culturing. To ensure the same starting conditions for all cultures of an experiment, cultures were mixed and divided again 24 h before treatment. Elicitor was prepared by the procedure described previously, 12) and was applied to 100 mg/ml E-FOl, the elicitor preparation of the wilt-inducing fungus F. oxysporum lycopersici. The cells were harvested at different time points by centrifugation at 1000 g, snap freezing in liquid nitrogen, and were stored at À80 C until analysis.
Chromatographic separation. Ground cells ($5 g) were used to prepare the crude extract with 10 ml of buffer A (25 mM Tris/HCl pH 7.5, 5 mM MgCl 2 , 5 mM EDTA, 1 mM DTT, 5% w/v glycerol, 20 mM -glycerophosphate, and 10 mM NaF) containing 1 mM phenylmethylsulfonyl fluoride, 10 mM benzamidine, and 1 mM Na 3 VO 4 . After 30 min of centrifugation at 100,000 g, supernatant containing 10 mg of total protein was loaded on the strong anion-exchange column Resource Q (6 ml, Amersham Pharmacia Biotech, Munich, Germany) equilibrated with buffer A. After wishing with 30 ml of buffer A, the column was eluted with an 80-ml linear gradient of 0 to 500 mM NaCl in buffer A. Fractions were analyzed by in-solution assay or in-gel kinase assay. Relative activity was calculated as described previously.
12)
In-solution assay and in-gel kinase assay. For kinase determination in solution, 5 ml of sample was mixed with reaction buffer to give a final volume of 15 ml containing 25 mM Tris/HCl pH 7.5, 5 mM MgCl 2 , 1 mM EGTA, 1 mM DTT, 0.5 mg/ml of myelin basic protein (MBP, Upstate Biotechnology, Lake Placid, NY), 25 mM ATP, and 1 mCi 32 P-ATP. Incubation at room temperature was stopped after 20 min by the addition of SDS sample buffer. The unincorporated 32 P-ATP was separated from the MBP by SDS-gel electrophoresis.
To measure the kinase activity in the SDS page gel, 20 ml of sample was loaded on a 10% w/v polyacrylamide gel embedded with 0.3 mg/ml of MBP in the separating gels as substrate for kinase. After electrophoresis, the proteins were renatured and assayed for kinase activity, as described by Zhang and Klessig. 14) Activities were visualized by autoradiography and with a phosphor imager (Cyclone, Phosphor Storage Systems, Madison, WI).
Inhibitor studies. Purine analogs were synthesized, 15, 16) and SB203580 and ML3403 were synthesized by Dr. Laufer (Department of Pharmaceutical and Medical Chemistry, Eberhard Karls University, Tuebingen, Germany). A 1-mg/ml solution in DMSO was diluted in water to a final concentration of 10 mM in the in-solution kinase assay. Relative activity was calculated as described previously.

Results
Purification of an elicitor-induced MAPK from photoautotrophic cultured cells of tomato
To analyze the inhibitory effect of purine-based compounds on the activity of plant MAPK, it was required to purify the activated form of a MAPK from plants as a test system. It has been found that stimuliinduced MAPKs purified from photoautotrophic cultured cells of tomato by anion-exchange chromatography can be used for inhibitor study.
12) Hence we activated MAPKs from photoautotrophic cultures of tomato by treatment with 100 mg/ml of E-Fol, the elicitor preparation of the wilt-inducing fungus F. oxysporum lycopersici. Elicitor-induced MAPK was purified from the protein extract of cells treated with E-Fol for 5 min by anion-exchange chromatography. As shown by in-solution assay (Fig. 1A ), we were able to separate two peaks with myelin basic protein (MBP)-phosphorylation activity after E-Fol treatment. To ensure that the different activity peaks eluted from the Resource Q column were due to different MAPKs, we tested the activity of MBPphosphorylating kinases by in-gel kinase assay involving de-and re-naturation cycles. Proteins purified by Resource Q column were subjected to electrophoresis in SDS-PAGE gel that contained the MBP. After de-and re-naturation, we determined the kinase activities. Fraction 17 and 18 contained high MBP-phosphorylation activities in the E-Fol-treated cell extracts. In contrast, fraction 12, which showed MBP-phosphorylation activity, did not contain MAPK (Fig. 1B) . Fraction 18, which contained the highest MAPK activity, was selected for further inhibitory studies.
The activity of plant MAPK was strongly inhibited by staurosporine but not by SB203580 or ML3403
Initially we determined the inhibition effect on the activity of MAPK using staurosporine, SB203580, and ML3403, reported to be inhibitors of particular serine/ threonine protein kinases. Staurosporine presents two main conformational states, corresponding to a chair and a boat conformation of the tetrahydropyran ring, 17) and is a nonspecific inhibitor of many serine/threonine protein kinases. The pyridinyl imidazole SB203580 is an inhibitor of MAPKs and has been extremely useful in identifying some of the physiological roles of MAPKs in the cell-signaling pathways in mammals.
5) The high degree of specificity of SB203580 is indicated by its failure to affect the activities of a number of other protein kinases.
18) ML3403 belongs to the second generation of diarylimidazole-type inhibitors. It has been reported to be a specific inhibitor of p38 MAPK of mammals.
19) The strategy of these compounds in inhibiting protein kinase is competitive with respect to ATP.
To examine the inhibition effects of staurosporine, SB203580, and ML3403, 5 ml of MAPK fraction (fraction 18) was incubated with reaction buffer containing 25 mM ATP, 1 mCi 32 P-ATP, and 10 mM of staurosporine, SB203580, or ML3403. MAPK activity was analyzed by in-solution assay using myelin basic protein (MBP) as an artificial substrate. The results of the experiment, shown in Fig. 2 , have been quantified; staurosporine inhibited 89.6% of MAPK activity, whereas SB203580 and ML3403 inhibited only 3.6% and 9.4% of activity respectively.
6-Benzylaminopurine (BAP) derivatives displayed different inhibitory activities
Roscovitine (3), Olomucine (2), and Bohemine (1) are cytokinin derivatives, but they have additional substituents at positions C2 and N9. These compounds have been reported to have inhibitory effects on the activity of CDKs, 16, 20, 21) and different potencies to inhibit the activity of plant MAPKs. 12) This indicates that a minor modification of the cytokinin structure can have a dramatic impact on protein kinase activity and selectivity.
Trisubstituted purine derivatives were synthesized, 15, 16) and the most of them were tested to investigate their plant MAPK inhibitors in this study for the first time (Figs. 3A and 4A) . To determine the basic relationship between their chemical structures and inhibitory effects on MAPK activity, initially we tested 12 6-bezylaminopurine (BAP)-type compounds. The activity of MBP-phosphorylation was analyzed by insolution assay in the presence of inhibitors 10 mM of the individual BAP derivatives. Figure 3B 9), and D.2.1.4 (10) inhibited the activity of MAPK by 50-80%, while the other compounds had smaller effects on MBP-phosphorylation activity. The (R)-(1-ethyl-2-hydroxyethyl)amino, 2-bis-(2-hydroxyethyl)amino, and (2-hydroxyethyl)thio substituents at C2 caused increased inhibitory effects, while the methythio substituent in position C2 had less effect. The different substituents at position N9 also showed different inhibitory effects on MAPK activity. Olomoucine (2) and A.2.1.1 (4) inhibited 43% and 58% of activity respectively, whereas A.3a.1.1 (12) did not inhibit the activity of MAPK.
C2, C6, and N9-substituted purines had different potency in inhibiting the activity of MAPK
The inhibitory effects of various trisubstituted purines on the activity of MAPK were analyzed by in-solution assay in the presence of 25 mM ATP. When 10 mM of inhibitors A.2.C.6 (26), A.2.C.Cl (27), A.2.2.1 (29), A.2.P.25 (22), A.H.8.Cl (30), and A.H.4.1 (32) was used individually in the reaction, no inhibition in MBPphosphorylation activity was observed, whereas the other C2, C6, and N9-substituted purine analogs inhibited the activity of MAPK by 40-80% (Fig. 4B) . The 3,3-dimethylallylamino, 2-hydroxybenzylamino, 3-hydroxybenzylamino, and methylamino substituents at C6 caused increased inhibitory effects, while 4-hydroxybenzylamino, cyclohexylmethylamino, and amino at position C6 did not show inhibitory activity on MAPK. The presence of 10 mM A.2.C.6 (26), a 6-benzythiopurine analog, did not act as an inhibitor of MAPK, whereas A.2.3.6 (19), a 6-(3-hydroxybenzyl)aminopurine derivative that has the same substituents at positions C2 and N9, inhibited 60% of MBP-phosphorylation activity. In addition, LGR494 (23) inhibited 49% of activity, whereas A.2.C.Cl (27) enhanced the activity of MAPK rather than inhibiting it. A, Chemical structure of BAP derivatives. B, MBP-phosphorylation activity was analyzed by in-solution assay in the presence of 10 mM inhibitor. The activity was quantified as described in Fig. 2 . Each bar represents the mean of AE SD of three replicates.
Replacement of the hydroxypropylamino group of A.2.C.6 (26) with chloro residue, A.2.C.Cl (27), did not increase inhibitory activity. A.1.2.1 (28), and A.2.2.1 (29), 6-(3,3-dimethylallylamino)purine derivatives, displayed significantly different effects on the activity of MAPK. The (R)-(1-ethyl-2-hydroxyethyl)amino substituents at C2 from 2-hydroxybenzylaminopurine caused increased inhibitory effects (Fig. 4B , compare OCII (13) and other 2-hydroxybenzylaminopurine derivatives). 10 mM of A.1.2.1 (28) inhibited the MBPphosphorylation activity by 55.8%, while A.2.2.1 (29) inhibited 3.7% of activity (Fig. 4B) . This indicates that the substituent of dimethylallyamino at the R3 position probably has an effect in increasing the affinity of the chemical to the enzyme.
Discussion
A number of novel low-molecular-weight proteinkinase inhibitors have been used to investigate the physiological functions of protein kinases, because they can be used simply and rapidly to block endogenous kinase activity. Most of the available protein kinase inhibitors act by competing for the ATP binding domain of the kinase, but the basis for their specificity mediates in their interaction with residues other than those that bind ATP directly.
3) The structural basis of the selectivity of SB compounds has been studied by comparative crystallography. 7) In addition, these compounds have been used to identify the novel physiological roles and substrates of MAPK. 8, 18) Purine-based compounds have found new applications as inhibitors of p38 MAPK, 7) CDKs, 15) HSP90, 22) Src kinase, 23) and sulfotransferases. 24) C2, C6, and N9-trisubstituted purines have shown different inhibitory effects on p34 cdc2 /cyclin B kinase activity. 10, 15) Different inhibitory potencies of Bohemine, Olomoucine, and Roscovitine versus plant MAPKs have been reported. 12) This indicates that the inhibitors can be useful in the characterization of plant MAPK, and suggest the possibility of inhibitor development mediated by interaction between chemical structure and protein kinase structure using C2, C6, N9-trisubstituted purines.
Here we investigated the relationship between chemical structure and inhibitory activity using a set of 36 purine derivatives that have inhibitory effects on the LGR177 33
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(1-hydroxymethyl-2-ethylpropyl)amino Fig. 4 . Effects of C2, C6, and N9-Trisubstituted Purines on the Activity of Elicitor-Induced MAPK. A, Chemical structures of C2, C6, and N9-trisubstituted purines. B, MBP-phosphorylation activity was analyzed by in-solution assay in the presence of 10 mM inhibitor. Inhibitory activity was analyzed and quantified as described in Fig. 2 . Each bar represents the mean of AE SD of three replicates.
activity of CDK. The test with 6-benzylaminopurine (BAP) suggested that the inhibitory activity is dependent on substitutions at position C2 and N9 (Fig. 3B) . The activity of MAPK was strongly inhibited by Roscovitine (3) (C2: (R)-(1-ethyl-2-hydroxyethyl)amino) and A.2.1.31 (8) (C2: (2-hydroxyethyl)thio). The same effect of substitution at position C2 from BAP was observed by cytokinin-derived cyclin-dependent kinase inhibitors. 15) This suggests that the presence of a polar side-chain at position C2 is necessary for binding to an area of the ATP binding pocket. A.2.1.31 (8) , different only in that C2 nitrogen is replaced by sulphur as compared with Bohemine, inhibited 76.3% of MBP-phosphorylation activity, whereas Bohemine inhibited the activity of MAPK by 56%. This indicates that this change can led to further improvement of the inhibitory activity.
Isopropyl and methyl substitution at position N9 of BAP increased the inhibitory activity (Fig. 3B , compare Olomoucine (2) and A.3a.1.1 (12), A.2.1.1 (4), and A.3a.1.1 (12) ). This indicates that the polar side-chain at the N9 position results in a loss of inhibitory activity, but the increased inhibitory activity of A.1.2.1 (28) was caused by methyl substitution rather than isopropyl substitution (Fig. 4B ). We hypothesize that the different effects of alkyl substitution on the activity of MAPK may be mediated by C6 substitution, although further experiments are required to determine the role of N9 substitution in the interaction between the inhibitors and MAPKs.
The benzylthio substituents at C6 did not show inhibitory activity on MAPK, whereas benzylamino at position C6 caused an increased inhibitory effect (Figs. 3B and 4B, compare Bohemine (1) and A.2.C.6 (26)). It is speculated that benzylthio sulphur does not accept a hydrogen bond between the inhibitor compound and the enzyme. The crystal structure of Olomoucine (2) in complex with ERK2 displays a conserved hydrogen bond between Met106N and purine N7, and an additional bond from the benzylamino N to Met106O. 7) In addition, the purine ring, Olomoucine (2) and Roscovitine (3), bind in the same region as the purine ring of ATP, and the benzyl group contacts outside of the ATP-binding pocket. 10) These findings indicate that the hydrogen bond is important to the interaction between the inhibitors and the ATP-binding site of protein kinase, and suggest that the benzyl ring of the BAP derivatives enables the inhibitor to make contact with the enzyme.
A significantly increased inhibitory effect on CDK1/ cyclin B activity when the position 2 or 3 of benzyl is decorated with one hydroxyl group has been found. 16) However, according to our present studies, the addition of a hydroxyl group at the 6-(benzylamino) substituent did not alter the inhibitory activity (Figs. 3B and 4B, compare Bohemine (1) and A.2.3.6 (19), Roscovitine (3) and OC II (13)). These different effects might be mediated by the different structure of the enzymes.
Selectivity is a major issue in the development of protein kinase inhibitors, because most of the important residues in the ATP-binding site are conserved. However, our data suggest that it is possible to develop highly selective kinase inhibitors by modification of the chemical structure. This study shows that C2, C6, and N9-trisubstituted purines are quite useful in constructing new, more active MAPK inhibitors which regulate structure-based selectivity.
The data obtained should be useful in developing new and more active MAPK inhibitors based on structurebased selectivity to complement the knock-out and knock-down approaches. With respect to the general importance of MAPK mediated signaling, the results might be important even beyond the field of plant science in further developing C2, C6, and N9-trisubstituted purines as tools in signal transduction research.
